After transfection with Mir204 inhibitor and Mir211 inhibitor, the viability of CIA FLS was significantly increased (p<0.0001), suggesting that Mir204/Mir211 are important regulators of FLS proliferation during RA development. The gene discussed is MIR204; the disease is rheumatoid arthritis.